Mycophenolate mofetil therapy for inflammatory eye disease
Mycophenolate mofetil therapy for inflammatory eye disease
复制标题
DOI：
10.1016/j.ophtha.2005.02.020
复制
发表时间：
2005-08-01
期刊：
影响因子：
13.7
通讯作者：
Dunn, JP
中科院分区：
文献类型：
--
作者：
Thorne, JE;Jabs, DA;Dunn, JP
目的：为了评估治疗结果与霉酚酸酯在炎症性眼病patients with inflammatory eye diseases.Design：Retrospective case series.Participants：84例连续的炎症性眼病患者在学术转诊center.Methods：病历进行了审查与霉酚酸酯治疗。记录吗替麦考酚酯的剂量、对治疗的反应、泼尼松的剂量、其他免疫抑制药物的使用以及与使用吗替麦考酚酯相关的副作用。
Purpose: To evaluate treatment outcomes with mycophenolate mofetil in patients with inflammatory eye disease.Design: Retrospective case series.Participants: Eighty-four consecutive patients with inflammatory eye disease treated with mycophenolate mofetil at an academic referral center.Methods: Medical records were reviewed for treatment with mycophenolate mofetil. Dose of mycophenolate mofetil, response to therapy, dose of prednisone, use of other immunosuppressive drugs, and side effects associated with the use of mycophenolate mofetil were recorded.Main Outcome Measures: Ability to control ocular inflammation with mycophenolate mofetil and to taper prednisone to